These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 9653432)

  • 41. BRCA1 and BRCA2 and breast cancer incidence: a review.
    Bishop DT
    Ann Oncol; 1999; 10 Suppl 6():113-9. PubMed ID: 10676562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.
    Welcsh PL; King MC
    Hum Mol Genet; 2001 Apr; 10(7):705-13. PubMed ID: 11257103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
    Johannsson O; Ostermeyer EA; Håkansson S; Friedman LS; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King MC; Borg A
    Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.
    Grimmond SM; Palmer JM; Walters MK; Scott C; Nancarrow DJ; Teh BT; Elmes C; Pyke C; Khoo SK; Bennett I; Wetzig N; Hayward NK
    Hum Genet; 1996 Jul; 98(1):80-5. PubMed ID: 8682513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
    Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
    JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC).
    Shen D; Vadgama JV
    Oncol Res; 1999; 11(2):63-9. PubMed ID: 10489161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
    Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
    J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.
    Lalloo F; Cochrane S; Bulman B; Varley J; Elles R; Howell A; Evans DG
    J Med Genet; 1998 Jan; 35(1):10-2. PubMed ID: 9475087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The genetics of inherited breast cancer.
    Gayther SA; Pharoah PD; Ponder BA
    J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):365-76. PubMed ID: 10819531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening and clinical implications for BRCA1 and BRCA2 mutation carriers.
    Plon SE
    J Mammary Gland Biol Neoplasia; 1998 Oct; 3(4):377-87. PubMed ID: 10819532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing.
    Gayther SA; Ponder BA
    Mol Med Today; 1997 Apr; 3(4):168-74. PubMed ID: 9134530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure.
    Spitzer E; Abbaszadegan MR; Schmidt F; Hauser A; Buwitt U; Lauter FR; Pötschick K; Krocker J; Elling D; Grosse R
    Int J Cancer; 2000 Feb; 85(4):474-81. PubMed ID: 10699917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
    Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
    Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical management of BRCA1- and BRCA2-associated breast cancer.
    Karp SE
    Semin Surg Oncol; 2000 Jun; 18(4):296-304. PubMed ID: 10805951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.
    Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J
    Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.
    Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P
    Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.
    Shih HA; Nathanson KL; Seal S; Collins N; Stratton MR; Rebbeck TR; Weber BL
    Clin Cancer Res; 2000 Nov; 6(11):4259-64. PubMed ID: 11106241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.
    Garvin AM; Attenhofer-Haner M; Scott RJ
    J Med Genet; 1997 Dec; 34(12):990-5. PubMed ID: 9429140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.